Small Pharma Inc.
DMTTF · OTC
5/31/2023 | 2/28/2023 | 11/30/2022 | 8/31/2022 | |
|---|---|---|---|---|
| Market Cap | $22,299 | $29,656 | $31,100 | $102,639 |
| - Cash | $13,152 | $18,537 | $22,744 | $27,145 |
| + Debt | $548 | $610 | $0 | $0 |
| Enterprise Value | $9,695 | $11,729 | $8,356 | $75,494 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$5,546 | -$4,224 | -$7,123 | -$7,448 |
| % Margin | – | – | – | – |
| Net Income | -$5,644 | -$2,373 | -$7,156 | -$7,456 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.018 | -0.007 | -0.022 | -0.023 |
| % Growth | -138.5% | 66.8% | 3.9% | – |
| Operating Cash Flow | -$5,759 | -$4,550 | -$5,358 | -$5,999 |
| Capital Expenditures | $0 | -$16 | -$2 | -$0 |
| Free Cash Flow | -$5,759 | -$4,566 | -$5,360 | -$5,999 |